A detailed history of Cottage Street Advisors LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Cottage Street Advisors LLC holds 4,641 shares of ABBV stock, worth $835,380. This represents 0.5% of its overall portfolio holdings.

Number of Shares
4,641
Previous 4,635 0.13%
Holding current value
$835,380
Previous $795 Million 15.28%
% of portfolio
0.5%
Previous 0.47%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$163.84 - $199.33 $983 - $1,195
6 Added 0.13%
4,641 $917 Million
Q2 2024

Jul 23, 2024

SELL
$154.79 - $180.76 $11,609 - $13,557
-75 Reduced 1.59%
4,635 $795 Million
Q1 2024

Apr 22, 2024

SELL
$159.82 - $182.1 $4,315 - $4,916
-27 Reduced 0.57%
4,710 $858 Million
Q4 2023

Jan 18, 2024

SELL
$137.6 - $154.97 $3,164 - $3,564
-23 Reduced 0.48%
4,737 $740 Million
Q3 2023

Nov 06, 2023

BUY
$133.59 - $154.65 $45,019 - $52,117
337 Added 7.62%
4,760 $709 Million
Q2 2023

Jul 24, 2023

SELL
$132.51 - $164.9 $8,480 - $10,553
-64 Reduced 1.43%
4,423 $596 Million
Q1 2023

Apr 21, 2023

BUY
$144.61 - $166.54 $648,865 - $747,264
4,487 New
4,487 $715 Million
Q3 2022

Oct 27, 2022

BUY
$134.21 - $153.93 $1,342 - $1,539
10 Added 0.22%
4,484 $602,000
Q2 2022

Jul 22, 2022

BUY
$137.62 - $174.96 $2,614 - $3,324
19 Added 0.43%
4,474 $685,000
Q1 2022

Apr 20, 2022

BUY
$131.98 - $163.75 $2,243 - $2,783
17 Added 0.38%
4,455 $722,000
Q4 2021

Jan 13, 2022

BUY
$107.43 - $135.93 $24,279 - $30,720
226 Added 5.37%
4,438 $601,000
Q3 2021

Oct 12, 2021

BUY
$106.4 - $120.78 $20,535 - $23,310
193 Added 4.8%
4,212 $454,000
Q2 2021

Jul 20, 2021

BUY
$105.21 - $117.21 $18,096 - $20,160
172 Added 4.47%
4,019 $453,000
Q1 2021

Apr 22, 2021

BUY
$102.3 - $112.62 $9,616 - $10,586
94 Added 2.5%
3,847 $416,000
Q4 2020

Jan 12, 2021

BUY
$80.49 - $108.67 $15,695 - $21,190
195 Added 5.48%
3,753 $402,000
Q3 2020

Oct 08, 2020

BUY
$85.91 - $100.83 $35,910 - $42,146
418 Added 13.31%
3,558 $312,000
Q2 2020

Jul 09, 2020

BUY
$73.37 - $98.18 $2,934 - $3,927
40 Added 1.29%
3,140 $308,000
Q3 2017

Oct 17, 2017

BUY
$69.85 - $89.22 $216,534 - $276,582
3,100
3,100 $275,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Cottage Street Advisors LLC Portfolio

Follow Cottage Street Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cottage Street Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cottage Street Advisors LLC with notifications on news.